Zihni Mert Duman1, Muhammed Bayram1, Barış Timur1, Sinem Aydın2, Kadriye Memiç Sancar3, Mustafa Yıldız3

1Clinic of Cardiovascular Surgery, İstanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Türkiye
2Clinic of Radiology, İstanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Türkiye
3 Clinic of Cardiology, İstanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Türkiye

Keywords: Dissection; lower extremity; reperfusion; intermittent claudication


Lower extremity hypoperfusion occurs in 5.7-30% of Stanford type B aortic dissection cases. A 53-year-old male patient presented with type B aortic dissection. His left femoral pulse was not palpable. The proximal left common iliac artery was nearly occluded in computed tomography angiography. There was no extremitythreatening rest pain, but there was intermittent claudication at 100 meters. Cross femoral bypass was planned for the patient under elective conditions. After two months, the left femoral pulse was palpable, and the patient no longer had intermittent claudication. In this study, we report that lower extremity hypoperfusion, which developed after acute type B aortic dissection resolved without open and endovascular surgery.


Complicated Stanford type B aortic dissection (TBAD) shows different clinical presentations such as aortic rupture, hypotension, shock, neurologic sequelae, and malperfusion syndrome (visceral or lower extremity)(1). Approximately 25-40% of TBAD are of complicated nature(2). The early mortality rate of patients with complicated TBAD is significantly higher than patients with uncomplicated TBAD.

Current guidelines recommend that patients diagnosed with complicated acute TBAD should receive immediate TEVAR after initiation of anti-impulse medical therapy(3). The purpose of TEVAR is to endovascularly close the entry tear, reduce the pressure of the false lumen, induce thrombosis and restore normal blood flow(4).

Lower extremity hypoperfusion (LEH) due to TBAD is an abnormal pulse examination accompanying leg pain, pallor, paresthesia, or paralysis(5). LEH occurs in 5.7-30% of TBAD cases(6). In this case study, we report that LEH developing after acute TBAD resolves without open and endovascular surgery.

Case Report

A 53-year-old male patient presented to the emergency department with a sudden onset of chest and back pain. On examination, blood pressure was 175/85 mmHg, rhythm was 105 per minute, and the left femoral pulse was not palpable. There were no problems in the transthoracic echocardiography and electrocardiogram. Thoracoabdominal computed tomography angiography (CTA) was performed with suspicion of aortic dissection. On CTA, TBAD was starting from the left subclavian artery orifice and ending at the bilateral common iliac arteries. Thoracic aorta diameter was 37 mm and false lumen diameter was 17 mm. The proximal left common iliac artery was nearly occluded by hypodense thrombus material. Blood flow was supplied to the left lower extremity by a very thin true lumen (TL) in the common iliac artery (Figure 1.a-c). The patient was started on anti-impulse, antihypertensive, and anticoagulation treatment in the intensive care unit (ICU).

Shock, neurological sequelae, visceral malperfusion syndrome, and persistent pain did not develop. Although the left femoral pulse was not palpable, the patient did not develop rest pain threatening the left lower extremity. Since there was no acute ischemia threatening the extremity; TEVAR or emergency surgery was not planned.

After two days, the patient was transferred to the service. At the follow-up visit, the patient had intermittent claudication (IC) in the left lower extremity at 100 meters. The left ankle brachial pressure index (ABI) measurement was 0.69. Right ABI measurement was 1.01. Cross-femoral bypass was planned for the patient under elective conditions. The patient was discharged with oral antihypertensive and anti-impulse therapy on the fifth day of hospitalization.

When the patient was checked for planned vascular surgery two months later, the IC had decreased. The walking distance was over 500 meters. Left ABI measurement was 0.95. It was decided to perform CTA. In CTA, type B chronic dissection was observed. However, there was no appearance of thrombus occluding the left common iliac artery orifice. The left common iliac artery was supplied with a wider TL (Figure 2.a-c). Under these circumstances, it was decided not to perform cross-femoral bypass surgery on the patient. In the one-year follow-up of the patient, claudication symptoms did not recur.


LEH due to AD is one of the most feared clinical scenarios. The concern about LEH is not just the risk of amputation. The presence of LEH is statistically associated with higher in-hospital mortality(7). The pulse examination in LEH is definitely abnormal. In the absence of a pulse, it is necessary to evaluate whether the extremity is under threat. In a systematic review by Gargiulo et al., only 13% of cases that developed LEH due to TBAD did not have leg-threatening ischemia(6). In these cases, medical treatment such as uncomplicated TBAD is seen as the gold standard. However, if there is ischemia threatening the leg, endovascular or open surgery should be planned according to the morphology of the dissection. Causes such as the collapse of the true aortic lumen in the abdominal aorta or iliac obstruction may require different treatments(8). As in renal and visceral ischemia, TEVAR, fenestration, or both can be performed endovascularly. In TEVAR, it is planned to close the entrance tear, restore normal blood flow, and correct ischemia. TEVAR is a good option if conditions such as abnormal capillary filling time, paresthesia, paralysis, or rest pain in the leg are present. We did not plan TEVAR as there was no leg-threatening ischemia. The current approach in surgical treatment is extra-anatomical bypass. Cross-femoral bypass is preferred if the flow and structure of the contralateral femoral artery are suitable for bypass. If there is a flow problem in both femoral arteries, axillo-bifemoral bypass is preferred(6).

In our case, dissection was the most probable diagnosis, since the left femoral artery pulse was not palpable and there was chest and back pain. At this stage, we believe it is crucial to determine whether the lack of a pulse is due to dissection or peripheral arterial embolism, because otherwise, there may be delays in diagnosis and perhaps inappropriate treatment.

We did not plan a left lower extremity flow reconstruction at the first stage as there was no ischemic rest pain in the extremity. In clinical follow-ups, a cross-femoral bypass was planned because the patient had IC.

Changes in the flow pattern due to the dynamic nature of the dissections may resolve extremity hypoperfusion(9). Dissection-induced hypoperfusions are caused by branch vessel obstructions. Williams et al.(10) reported two types of branch vessel obstruction due to dissection: static and dynamic obstruction. In our case, it was seen that both static and dynamic obstruction caused hypoperfusion. Thrombus causing near-total stenosis at the level of the left common iliac artery was causing the static obstruction. The false lumen located to the left at the level of the abdominal aorta bifurcation caused dynamic obstruction in the true lumen.

In the two-month follow-up, the patient’s IC resolved spontaneously. As seen on the CTA, FL thrombosis at the level of the abdominal aorta bifurcation reduced the dynamic obstruction. Also, static obstruction regressed with the resolution of thrombus in the left common iliac artery. We believe that the synergy formed by the regression of both obstruction mechanisms resulted in minimal residual stenosis in the iliac artery.

In conclusion, peripheral artery surgery can be postponed for some time in TBAD patients with stable IC symptoms. We recommend a comprehensive reassessment of patients’ ischemic symptoms prior to peripheral artery surgery.

Cite this article as: Duman ZM, Bayram M, Timur B, Aydın S, Memiç Sancar K, Yıldız M. Spontaneous resolution of lower extremity hypoperfusion in type b aortic dissection: a case report. Koşuyolu Heart J 2022;25(2):216-218.

Peer Review

Externally peer-reviewed.

Author Contributions

Concept/Design - ZMD, MB, SA; Analysis/ Interpretation - ZMD, KMS ; Data Collection - BT, SA; Writing - ZMD, BT; Critical Revision - MY, MB; Final Approval - MY, KM; Overall Responsibility - ZMD, MB.

Conflict of Interest

All authors declare that they do not have conflict of interest.

Financial Disclosure

The authors declared that this study has received no financial support.


  1. Nauta FJ, Trimarchi S, Kamman AV, Moll FL, Herwaarden JA, Patel HJ, et al. Update in the management of type B aortic dissection. Vasc Med 2016;21(3):251-63. [Crossref]
  2. Fattori R, Cao P, De Rango P, Czerny M, Evangelista A, Nienaber C, et al. Interdisciplinary expert consensus document on management of type B aortic dissection. J Am Coll Cardiol 2013;61:1661-78. [Crossref]
  3. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo R, Eggebrecht Hi et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC) [published correction appears in Eur Heart J 2015 Nov 1;36(41):2779]. Eur Heart J 2014;35(41):2873-926. [Crossref]
  4. Andacheh ID, Donayre C, Othman F, Walot I, Kopchok G, White R. Patient outcomes and thoracic aortic volume and morphologic changes following thoracic endovascular aortic repair in patients with complicated chronic type B aortic dissection. J Vasc Surg 2012;56(3):644-50. [Crossref]
  5. White RA, Miller DC, Criado FJ, Dake MD, Diethrich EB, Greenberg RK, et al. Report on the results of thoracic endovascular aortic repair for acute, complicated, type B aortic dissection at 30 days and 1 year from a multidisciplinary subcommittee of the Society for Vascular Surgery Outcomes Committee. J Vasc Surg 2011;53(4):1082-90. [Crossref]
  6. Gargiulo M, Massoni CB, Gallitto E, Freyrie A, Trimarchi S, Faggioli G, et al. Lower limb malperfusion in type B aortic dissection: A systematic review. Ann Cardiothorac Surg 2014;3(4):351-67.
  7. Suzuki T, Mehta RH, Ince H, Nagai R, Sakomura Y, Weber F, et al. Clinical profiles and outcomes of acute type B aortic dissection in the current era: Lessons from the International Registry of Aortic Dissection (IRAD). Circulation 2003;108 Suppl 1:II312-7. [Crossref]
  8. Lakshmanan R, Aung M, Hoong CK. Limb ischaemia in a Stanford B aortic dissection into an abdominal aortic aneurysm. ANZ J Surg 2008;78:660-1. [Crossref]
  9. Plotkin A, Vares-Lum D, Magee GA, Han SM, Fleischman F, Rowe VL. Management strategy for lower extremity malperfusion due to acute aortic dissection. J Vasc Surg 2021;74(4):1143-51. [Crossref]
  10. Williams DM, Lee DY, Hamilton BH, Marx MV, Narasimham DL, Kazanjian SN, et al. The dissected aorta: Part III. Anatomy and radiologic diagnosis of branch-vessel compromise. Radiology 1997;203:37-44. [Crossref]

Figure and Tables